Cargando…

SAMD9 Promotes Postoperative Recurrence of Esophageal Squamous Cell Carcinoma by Stimulating MYH9‐Mediated GSK3β/β‐Catenin Signaling

Recurrence is a challenge to survival after the initial treatment of esophageal squamous cell carcinoma (ESCC). But, its mechanism remains elusive and there are currently no biomarkers to predict postoperative recurrence. Here, the possibility of sterile alpha motif domain‐containing protein 9 (SAMD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Qing, Luo, Hao, Dai, Fu‐Qiang, Wang, Ren‐Tao, Fan, Xiao‐Qing, Luo, Yuan‐Yuan, Deng, Meng‐Sheng, Wang, Yulun, Long, Tan, Guo, Wei, Xu, Bo, Xu, Cheng‐Xiong, Jin, Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10104667/ https://www.ncbi.nlm.nih.gov/pubmed/36757050 http://dx.doi.org/10.1002/advs.202203573

Ejemplares similares

TUBB4A interacts with MYH9 to protect the nucleus during cell migration and promotes prostate cancer via GSK3β/β-catenin signalling
por: Gao, Song, et al.
Publicado: (2022)

ENKUR recruits FBXW7 to ubiquitinate and degrade MYH9 and further suppress MYH9‐induced deubiquitination of β‐catenin to block gastric cancer metastasis
por: Liu, Jiahao, et al.
Publicado: (2022)

Evolution and divergence of the mammalian SAMD9/SAMD9L gene family
por: Lemos de Matos, Ana, et al.
Publicado: (2013)

circGSK3β promotes metastasis in esophageal squamous cell carcinoma by augmenting β-catenin signaling
por: Hu, Xueting, et al.
Publicado: (2019)

SAMD9 and SAMD9L in inherited predisposition to ataxia, pancytopenia, and myeloid malignancies
por: Davidsson, Josef, et al.
Publicado: (2018)

Silencing MYH9 blocks HBx-induced GSK3β ubiquitination and degradation to inhibit tumor stemness in hepatocellular carcinoma
por: Lin, Xian, et al.
Publicado: (2020)

Functional Study of SAMD9L in Familial Gastric Cancer
por: Kaixuan, Xu, et al.
Publicado: (2023)

Outcomes of Hematopoietic Cell Transplantation in Patients with Germline SAMD9/SAMD9L Mutations
por: Ahmed, Ibrahim A., et al.
Publicado: (2019)

Structure and function of an effector domain in antiviral factors and tumor suppressors SAMD9 and SAMD9L
por: Peng, Shuxia, et al.
Publicado: (2022)

Different expression of GSK3β and pS9GSK3β depending on phenotype of cervical cancer: possible association of GSK3β with squamous cell carcinoma and pS9GSK3β with adenocarcinoma
por: Ahn, Kwanghee, et al.
Publicado: (2019)

MYH9 nephropathy
por: Oh, Taehoon, et al.
Publicado: (2015)

Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes
por: Sahoo, Sushree S., et al.
Publicado: (2020)

Ataxia-pancytopenia syndrome with SAMD9L mutations
por: Gorcenco, Sorina, et al.
Publicado: (2017)

NHE9 induces chemoradiotherapy resistance in esophageal squamous cell carcinoma by upregulating the Src/Akt/β-catenin pathway and Bcl-2 expression
por: Chen, Junying, et al.
Publicado: (2015)

TET3 governs malignant behaviors and unfavorable prognosis of esophageal squamous cell carcinoma by activating the PI3K/AKT/GSK3β/β-catenin pathway
por: Zhu, Maoling, et al.
Publicado: (2022)

CDK9 binds and activates SGK3 to promote cardiac repair after injury via the GSK-3β/β-catenin pathway
por: Sun, Jiateng, et al.
Publicado: (2022)

Pediatric MDS and bone marrow failure-associated germline mutations in SAMD9 and SAMD9L impair multiple pathways in primary hematopoietic cells
por: Thomas, Melvin E., et al.
Publicado: (2021)

Glycoprotein PTGDS promotes tumorigenesis of diffuse large B-cell lymphoma by MYH9-mediated regulation of Wnt–β-catenin–STAT3 signaling
por: Hu, Shunfeng, et al.
Publicado: (2021)

Emerging phenotypes linked to variants in SAMD9 and MIRAGE syndrome
por: Suntharalingham, Jenifer P., et al.
Publicado: (2022)

MYH9 promotes cell metastasis via inducing Angiogenesis and Epithelial Mesenchymal Transition in Esophageal Squamous Cell Carcinoma
por: Yang, Bin, et al.
Publicado: (2020)

MYH9 Inhibition Suppresses TGF-β1-Stimulated Lung Fibroblast-to-Myofibroblast Differentiation
por: Sun, Xionghua, et al.
Publicado: (2021)

Germline SAMD9 Mutation in Siblings with Monosomy 7 and Myelodysplastic Syndrome
por: Schwartz, Jason R., et al.
Publicado: (2017)

β-Arrestin1 Promotes Colorectal Cancer Metastasis Through GSK-3β/β-Catenin Signaling- Mediated Epithelial-to-Mesenchymal Transition
por: Song, Qing, et al.
Publicado: (2021)

KCTD9 inhibits the Wnt/β-catenin pathway by decreasing the level of β-catenin in colorectal cancer
por: Yao, Hanhui, et al.
Publicado: (2022)

Transcriptional suppression of microRNA-27a contributes to laryngeal cancer differentiation via GSK-3β-involved Wnt/β-catenin pathway
por: Chen, Sheng, et al.
Publicado: (2017)

A familial SAMD9 variant present in pediatric myelodysplastic syndrome
por: Rahim, Mahvish Q., et al.
Publicado: (2023)

ENKUR expression induced by chemically synthesized cinobufotalin suppresses malignant activities of hepatocellular carcinoma by modulating β-catenin/c-Jun/MYH9/USP7/c-Myc axis
por: Hou, Rentao, et al.
Publicado: (2022)

Sortilin promotes glioblastoma invasion and mesenchymal transition through GSK-3β/β-catenin/twist pathway
por: Yang, Wei, et al.
Publicado: (2019)

Mannose Suppresses the Proliferation and Metastasis of Lung Cancer by Targeting the ERK/GSK-3β/β-Catenin/SNAIL Axis
por: Luo, Qingsong, et al.
Publicado: (2020)

GSK3β Is Involved in JNK2-Mediated β-Catenin Inhibition
por: Hu, Dong, et al.
Publicado: (2009)

SAT-173 SAMD9 (Sterile Alpha Motif Domain-Containing 9) Expression in Adrenocortical Tumors
por: Bueno, Ana C, et al.
Publicado: (2020)

P816: TRANSIENT MONOSOMY 7 IN SAMD9/9L SYNDROMES: IS IT SAFE TO WATCH AND WAIT?
por: Erlacher, M., et al.
Publicado: (2022)

Interferon‐γ inducible protein 30 promotes the epithelial–mesenchymal transition‐like phenotype and chemoresistance by activating EGFR/AKT/GSK3β/β‐catenin pathway in glioma
por: Chen, Ying, et al.
Publicado: (2023)

PRMT9 promotes hepatocellular carcinoma invasion and metastasis via activating PI3K/Akt/GSK‐3β/Snail signaling
por: Jiang, Hai, et al.
Publicado: (2018)

Myosin Heavy Chain 9 (MYH9)-Related Congenital Macrothrombocytopenia
por: Thurlapati, Aswani, et al.
Publicado: (2021)

A novel de novo MYH9 mutation in MYH9-related disease: A case report and review of literature
por: Ai, Qi, et al.
Publicado: (2020)

HMGA1 stimulates MYH9-dependent ubiquitination of GSK-3β via PI3K/Akt/c-Jun signaling to promote malignant progression and chemoresistance in gliomas
por: Que, Tianshi, et al.
Publicado: (2021)

Hypoxia activates Wnt/β-catenin signaling by regulating the expression of BCL9 in human hepatocellular carcinoma
por: Xu, Wei, et al.
Publicado: (2017)

TOPK promotes metastasis of esophageal squamous cell carcinoma by activating the Src/GSK3β/STAT3 signaling pathway via γ-catenin
por: Jiang, Yanan, et al.
Publicado: (2019)

Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humans
por: Buonocore, Federica, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_uq0j7vk7q08ugqcibb561tdgvr